Litton W Edwin 4
4 · Cellu Tissue Holdings, Inc. · Filed Dec 27, 2010
Insider Transaction Report
Form 4
Litton W Edwin
Gen'l Counsel, Sr. V.P.
Transactions
- Disposition to Issuer
Stock Option
2010-12-27−3,164→ 0 totalExercise: $2.55Exp: 2016-08-15→ Common Stock (3,164 underlying) - Disposition to Issuer
Stock Option
2010-12-27−3,842→ 0 totalExercise: $5.64Exp: 2018-04-07→ Common Stock (3,842 underlying) - Disposition to Issuer
Stock Option
2010-12-27−3,164→ 0 totalExercise: $2.55Exp: 2016-12-03→ Common Stock (3,164 underlying) - Disposition to Issuer
Stock Option
2010-12-27−3,503→ 0 totalExercise: $5.85Exp: 2017-04-09→ Common Stock (3,503 underlying) - Disposition to Issuer
Stock Option
2010-12-27−16,735→ 0 totalExercise: $5.28Exp: 2019-04-13→ Common Stock (16,735 underlying) - Disposition to Issuer
Stock Option
2010-12-27−9,706→ 0 totalExercise: $11.45Exp: 2020-01-27→ Common Stock (9,706 underlying)
Footnotes (1)
- [F1]On December 27, 2010, a wholly owned subsidiary of Clearwater Paper Corporation merged with Cellu Tissue Holdings, Inc. pursuant to a merger agreement entered into between Clearwater Paper and Cellu Tissue on September 15, 2010 (the "Merger"), as more fully described in the Cellu Tissue proxy statement dated December 1, 2010 filed with the SEC. In connection with the Merger, each outstanding Cellu Tissue option to purchase shares of common stock, whether or not vested, was cancelled and Reporting Person received a cash payment in an amount equal to the number of shares of common stock represented by each option, vested or unvested, multiplied by the excess, if any, of $12.00 over the exercise price per share under each option. Reporting Person's disposition of options in the Merger was approved by the Cellu Tissue board of directors.